[Reduction of myocardial infarction size after primary percutaneous coronary intervention]

Alf-Age R Pettersen1, Carl Müller, Bjørn Bendz

  • 1Hjerte-Lungesenteret, Hjerte-Lungesenteret, Ullevål universitetssykehus, 0407 Oslo. alf-age.pettersen@ulleval.no

Insights

Primary percutaneous coronary intervention (PCI) significantly reduces myocardial infarction size. Technetium 99m-tetrofosmin SPECT imaging shows a 60% reduction in hypoperfusion index six weeks post-PCI for ST-elevation myocardial infarction patients.

Area of Science:

  • Cardiology
  • Nuclear Medicine
  • Interventional Cardiology

Background:

  • Timely reperfusion is critical for reducing myocardial infarction size and improving patient prognosis.
  • Primary percutaneous coronary intervention (PCI) is increasingly used for acute myocardial infarction.
  • Technetium 99m-tetrofosmin SPECT is effective for assessing myocardial risk and infarct size via hypoperfusion index (HPI).

Purpose of the Study:

  • To evaluate the effectiveness of primary PCI in reducing final infarct size.
  • To assess changes in myocardial perfusion and infarct size over time using Technetium 99m-tetrofosmin SPECT.

Main Methods:

  • 20 patients with acute ST-elevation myocardial infarction underwent primary PCI within six hours of symptom onset.
  • Myocardium at risk and final infarct size were quantified using Technetium 99m-tetrofosmin SPECT.
  • Imaging was performed immediately before PCI, and at a few hours, one week, and six weeks after PCI.

Main Results:

  • The hypoperfusion index (HPI) decreased from 31% before PCI to 12% at six weeks, a 60% relative reduction (p < 0.01).
  • Anterior wall infarctions showed greater myocardium at risk initially (36%) compared to inferior wall infarctions (24%).
  • Anterior wall infarctions exhibited a higher salvage index compared to inferior wall infarctions.

Conclusions:

  • Primary PCI leads to a significant reduction in final infarct size in patients with acute ST-elevation myocardial infarction.
  • Technetium 99m-tetrofosmin SPECT demonstrates the efficacy of primary PCI in myocardial salvage.
Abstract